top of page
Better Life with Healthy Animals. GCVP Vaccines & Pharmaceuticals
Since our founding in 1973, we have led the animal biotechnology industry for over half a century, developing a wide range of vaccines and therapeutics to protect animals from countless diseases.
2010 ~ Present
2025 01 Selected as Most Recommended Brand 2025 (GVAX)
2025 01 Awarded Minister’s Commendation for Export Contribution (MAFRA)
2024 08 Produced clinical-grade extracellular vesicle therapeutics
2024 08 Certified as Clinical Trial Institution for Veterinary Pharmaceuticals
2024 03 Grand Prize, ESG Category – 2024 Social Contribution Awards
2023 12 FVC (FMD Vaccine Localization) incorporated as subsidiary
2023 08 Good Design Award (Ministry of Trade, Industry and Energy, Brand Category)
2023 08 ISO 37301 Certification (Compliance Management System)
2023 05 ISO 14001 Certification (Environmental Management System)
2023 04 No.1 National Preferred Brand in Veterinary Pharmaceuticals(Korea National Daily)
2023 02 ISO 9001 Certification (Quality Management)
2023 01 50th Anniversary of GCVP
2022 04 Yesan Campus KVGMP Certification
2022 04 Filed world’s first patent for tulathromycin formulation for dogs
2022 01 Relocated vaccine manufacturing facilities to Yesan Campus
2021 12 Excellence Award – Veterinary Pharmaceuticals Voluntary Inspection (MAFRA)
2017 01 Minister’s Award for Export Contribution (MAFRA)
1990 ~ 2009
2008 Quality Control Excellence Award (MAFRA)
2004 Oral PED Vaccine Patent (World’s First)
2003 Korea’s First Aquaculture Vaccine Approval (Flounder Edwardsiella)
2003 Vaccine Freeze Dryer Expansion
1999 Green Cross Veterinary Research Institute Established
1973 ~ 1989
1985 Technical partnership with Denkavit Nederland B.V.
1985 Expanded factory buildings at the Hwacheong Plant
1981 Expanded the vaccine plant and office facilities
1981 Signed a technology introduction agreement with Rhone Merieux, France
1973 Split off from Green Cross pharma with new ownership
bottom of page